4 hours Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains Zacks
GILD and GSK are in the spotlight in the biotech sector with quite a few regulatory and pipeline updates.
Biotech · Gilead (GILD) · Regeneron Pharma (REGN)
X